The five-year survival rate after total gastrectomy treatment is about 40% for patients with stage 3b gastric cancer, which can vary.
Gastric cancer is a malignant tumor of digestive system caused by Helicobacter pylori infection, heredity and other factors. Stage 3b represents one of the TNM stages, which is the development of cancer cells to the plasma membrane layer, the occurrence of more than seven lymph nodes metastasis, the absence of distant metastasis and other conditions.
In this period, according to the patient’s condition, total gastrectomy, radiotherapy and other methods are feasible for treatment. After active treatment, patients with stage 3b gastric cancer can obtain a five-year survival rate of about 40%, and the survival time can be relatively extended if they have a high degree of tolerance to the treatment and are in relatively good physical condition.